Alnylam Pharmaceuticals Ownership 2024 | Who Owns Alnylam Pharmaceuticals Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

95.02%

Insider Ownership

0.42%

Retail Ownership

4.56%

Institutional Holders

560.00

Alnylam Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAPITAL WORLD INVESTORS11.87%0.59%14,971,3432,182,10717.06%3,638,104,641Jun 30, 2024
VANGUARD GROUP INC9.92%0.06%12,507,778513,5174.28%3,039,390,054Jun 30, 2024
FMR LLC9.64%0.19%12,164,0382,196,04222.03%2,955,861,341Jun 30, 2024
BLACKROCK INC.7.57%0.05%9,547,663522,6565.79%2,320,082,109Jun 30, 2024
WELLINGTON MANAGEMENT GROUP LLP4.92%0.27%6,210,479-998,526-13.85%1,509,146,397Jun 30, 2024
BAILLIE GIFFORD & CO4.78%1.14%6,032,656-590,921-8.92%1,465,935,408Jun 30, 2024
CAPITAL INTERNATIONAL INVESTORS3.08%0.19%3,891,059239,8426.57%945,651,452Jun 30, 2024
DODGE & COX3.00%0.55%3,780,185-31,295-0.82%918,584,955Jun 30, 2024
STATE STREET CORP2.80%0.04%3,534,836343,46310.76%858,965,148,000Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/2.77%0.10%3,488,003-197,750-5.37%847,586,000Jun 30, 2024
CAPITAL RESEARCH GLOBAL INVESTORS2.58%0.17%3,255,648110,6613.52%791,139,627Jun 30, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.2.50%0.48%3,153,627280,7239.77%766,332,000Jun 30, 2024
NORGES BANK1.82%0.08%2,296,7812,296,781100.00%558,117,783Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.65%0.04%2,080,27578,5573.92%504,599,030Jun 30, 2024
JPMORGAN CHASE & CO1.41%0.04%1,772,87124,6821.41%430,807,702Jun 30, 2024
AMERICAN CENTURY COMPANIES INC1.07%0.20%1,354,169-19,485-1.42%329,063,460Jun 30, 2024
LEGAL & GENERAL GROUP PLC0.73%0.05%926,3305,1350.56%225,098,405Jun 30, 2024
BELLEVUE GROUP AG0.73%3.63%919,8341,5500.17%223,519,662Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC0.66%0.06%835,41376,76310.12%203,005,359Jun 30, 2024
NORTHERN TRUST CORP0.62%0.03%780,83541,2515.58%189,742,905,000Jun 30, 2024

Alnylam Pharmaceuticals's largest institutional shareholder is CAPITAL WORLD INVESTORS, holding 11.87% of the company's total share outstanding, currently valued at $3.64B. The top 10 institutional shareholders own together 60.35% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
IKARIAN CAPITAL, LLC0.00%6.35%1,500-119,300-98.76%36,450,000Jun 30, 2024
GHOST TREE CAPITAL, LLC0.05%5.20%68,40068,400100.00%16,621,200Jun 30, 2024
BRIDGER MANAGEMENT, LLC0.03%4.63%37,022-15,900-30.04%8,996,346Jun 30, 2024
BELLEVUE GROUP AG0.73%3.63%919,8341,5500.17%223,519,662Jun 30, 2024
DEEP TRACK CAPITAL, LP0.40%3.63%500,000-332,310-39.93%121,500,000Jun 30, 2024
EAGLE HEALTH INVESTMENTS LP0.06%3.25%76,25627,90057.70%18,530,208Jun 30, 2024
CASDIN CAPITAL, LLC0.13%3.17%170,000-188,000-52.51%41,310,000Jun 30, 2024
TRI LOCUM PARTNERS LP0.04%2.76%45,00045,000100.00%10,935,000Jun 30, 2024
AVIDITY PARTNERS MANAGEMENT LP0.18%2.29%222,000-21,000-8.64%53,946,000Jun 30, 2024
ROSENBLUM SILVERMAN SUTTON S F INC /CA0.03%2.29%35,200-270-0.76%8,553,600Jun 30, 2024
683 CAPITAL MANAGEMENT, LLC0.10%2.26%122,90087,100243.30%29,864,700Jun 30, 2024
ANTIPODES PARTNERS LTD0.19%2.16%238,74933,17016.13%59,431,740Jun 30, 2024
SILVERARC CAPITAL MANAGEMENT, LLC0.03%2.06%36,00036,000100.00%8,748,000Jun 30, 2024
RHENMAN & PARTNERS ASSET MANAGEMENT AB0.07%1.99%85,50043,200102.13%20,776,500Jun 30, 2024
SOFINNOVA INVESTMENTS, INC.0.12%1.87%147,92944,89343.57%35,946,747Jun 30, 2024
CAPTION MANAGEMENT, LLC0.39%1.83%489,600378,300339.89%118,972,800Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP0.20%1.83%250,0006,0002.46%60,750,000Jun 30, 2024
GHOST TREE CAPITAL, LLC0.02%1.71%22,500-37,500-62.50%5,467,500Jun 30, 2024
NOVO HOLDINGS A/S0.09%1.67%118,383--28,767,069Jun 30, 2024
ARTIA GLOBAL PARTNERS LP0.03%1.64%35,00035,000100.00%8,505,000Jun 30, 2024

The largest Alnylam Pharmaceuticals shareholder by % of total assets is IKARIAN CAPITAL, LLC. The company owns 1.50K shares of Alnylam Pharmaceuticals (ALNY), representing 6.35% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NORGES BANK1.82%0.08%2,296,7812,296,781100.00%558,117,783Jun 30, 2024
FMR LLC9.64%0.19%12,164,0382,196,04222.03%2,955,861,341Jun 30, 2024
CAPITAL WORLD INVESTORS11.87%0.59%14,971,3432,182,10717.06%3,638,104,641Jun 30, 2024
ORBIS ALLAN GRAY LTD0.57%1.09%721,053721,053100.00%175,215,879Jun 30, 2024
BLACKROCK INC.7.57%0.05%9,547,663522,6565.79%2,320,082,109Jun 30, 2024
VANGUARD GROUP INC9.92%0.06%12,507,778513,5174.28%3,039,390,054Jun 30, 2024
CAPTION MANAGEMENT, LLC0.39%1.83%489,600378,300339.89%118,972,800Jun 30, 2024
STATE STREET CORP2.80%0.04%3,534,836343,46310.76%858,965,148,000Jun 30, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.2.50%0.48%3,153,627280,7239.77%766,332,000Jun 30, 2024
GOLDMAN SACHS GROUP INC0.41%0.02%514,667254,64897.93%125,063,967Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.0.20%0.11%254,000254,000100.00%61,722,000Jun 30, 2024
ORBIMED ADVISORS LLC0.20%1.21%250,300250,300100.00%60,822,900Jun 30, 2024
CAPITAL INTERNATIONAL INVESTORS3.08%0.19%3,891,059239,8426.57%945,651,452Jun 30, 2024
INVESCO LTD.0.31%0.02%392,841214,528120.31%95,460,363Jun 30, 2024
D. E. SHAW & CO., INC.0.22%0.06%279,398176,011170.24%67,893,714Jun 30, 2024
FRONTIER CAPITAL MANAGEMENT CO LLC0.13%0.41%168,442168,442100.00%40,931,406Jun 30, 2024
BANK OF AMERICA CORP /DE/0.50%0.01%631,112146,21930.15%153,360,216Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC0.22%0.10%271,619130,48292.45%65,862,175Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)0.10%0.48%119,800119,800100.00%29,111,400Jun 30, 2024
LMR PARTNERS LLP0.17%0.43%211,900112,700113.61%51,491,700Jun 30, 2024

As of Jun 30 2024, Alnylam Pharmaceuticals's largest institutional buyer is NORGES BANK. The company purchased 2.30M stocks of ALNY, valued at $558.12M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLINGTON MANAGEMENT GROUP LLP4.92%0.27%6,210,479-998,526-13.85%1,509,146,397Jun 30, 2024
BAILLIE GIFFORD & CO4.78%1.14%6,032,656-590,921-8.92%1,465,935,408Jun 30, 2024
LOGOS GLOBAL MANAGEMENT LP----500,000-100.00%-Jun 30, 2024
SQUAREPOINT OPS LLC0.08%0.04%98,794-481,647-82.98%24,006,942Jun 30, 2024
VESTAL POINT CAPITAL, LP----350,000-100.00%-Jun 30, 2024
DEEP TRACK CAPITAL, LP0.40%3.63%500,000-332,310-39.93%121,500,000Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.----287,627-100.00%-Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC----234,400-100.00%-Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.----206,255-100.00%-Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA0.60%0.21%758,528-202,976-21.11%184,322,304Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/2.77%0.10%3,488,003-197,750-5.37%847,586,000Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.03%0.07%43,975-191,631-81.34%10,685,925Jun 30, 2024
CASDIN CAPITAL, LLC0.13%3.17%170,000-188,000-52.51%41,310,000Jun 30, 2024
PALO ALTO INVESTORS LP----182,766-100.00%-Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.00%0.08%1,850-178,295-98.97%449,550Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.53%0.03%673,702-124,743-15.62%163,709,488Jun 30, 2024
IKARIAN CAPITAL, LLC0.00%6.35%1,500-119,300-98.76%36,450,000Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC0.01%0.01%13,283-113,084-89.49%3,227,769Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----110,759-100.00%-Jun 30, 2024
NATIONAL BANK OF CANADA /FI/0.00%0.00%626-107,784-99.42%152,273Jun 30, 2024

As of Jun 30 2024, Alnylam Pharmaceuticals's biggest institutional seller is WELLINGTON MANAGEMENT GROUP LLP. The company sold -1.00M shares of ALNY, valued at $1.51B.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NORGES BANK1.82%0.08%2,296,7812,296,781100.00%558,117,783Jun 30, 2024
ORBIS ALLAN GRAY LTD0.57%1.09%721,053721,053100.00%175,215,879Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.0.20%0.11%254,000254,000100.00%61,722,000Jun 30, 2024
FRONTIER CAPITAL MANAGEMENT CO LLC0.13%0.41%168,442168,442100.00%40,931,406Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.08%0.11%95,00095,000100.00%23,085,000Jun 30, 2024
BANK OF AMERICA CORP /DE/0.07%0.00%83,50083,500100.00%20,290,500Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.06%1.54%71,70071,700100.00%17,423,100Jun 30, 2024
GHOST TREE CAPITAL, LLC0.05%5.20%68,40068,400100.00%16,621,200Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.04%0.16%54,14254,142100.00%13,156,506Jun 30, 2024
J. GOLDMAN & CO LP0.04%0.35%50,30050,300100.00%12,222,900Jun 30, 2024
SOFINNOVA INVESTMENTS, INC.0.04%0.63%50,00050,000100.00%12,150,000Jun 30, 2024
TRI LOCUM PARTNERS LP0.04%2.76%45,00045,000100.00%10,935,000Jun 30, 2024
KYNAM CAPITAL MANAGEMENT, LP0.03%0.81%43,00043,000100.00%10,449,000Jun 30, 2024
SILVERARC CAPITAL MANAGEMENT, LLC0.03%2.06%36,00036,000100.00%8,748,000Jun 30, 2024
ARTIA GLOBAL PARTNERS LP0.03%1.64%35,00035,000100.00%8,505,000Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.02%0.02%31,29331,293100.00%7,616,531Jun 30, 2024
FJARDE AP-FONDEN (THE FOURTH SWEDISH NATIONAL PENSIONFUND)0.02%0.08%28,41528,415100.00%6,905,000Jun 30, 2024
ATIKA CAPITAL MANAGEMENT LLC0.02%0.58%24,50024,500100.00%5,953,500Jun 30, 2024
UBS OCONNOR LLC0.02%0.00%19,10019,100100.00%27,875Jun 30, 2024
DLD ASSET MANAGEMENT, LP0.01%0.77%16,20016,200100.00%3,936,600Jun 30, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.01%0.00%14,97114,971100.00%3,638,000Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.01%0.01%14,86314,863100.00%3,611,709Jun 30, 2024
MELQART ASSET MANAGEMENT (UK) LTD0.01%0.27%13,50013,500100.00%3,280,500Jun 30, 2024
NOMURA HOLDINGS INC0.01%0.01%11,30011,300100.00%2,745,900Jun 30, 2024
CENTIVA CAPITAL, LP0.01%0.04%10,50010,500100.00%2,551,500Jun 30, 2024
UBS OCONNOR LLC0.01%0.00%10,00010,000100.00%46,000Jun 30, 2024
READYSTATE ASSET MANAGEMENT LP0.01%0.08%9,6009,600100.00%2,332,800Jun 30, 2024
MBB PUBLIC MARKETS I LLC0.01%0.05%9,2009,200100.00%2,235,600Jun 30, 2024
NOMURA HOLDINGS INC0.01%0.00%8,8008,800100.00%2,138,400Jun 30, 2024
DEUTSCHE BANK AG\0.01%0.00%8,7008,700100.00%2,114,100Jun 30, 2024
CINCTIVE CAPITAL MANAGEMENT LP0.01%0.10%8,3008,300100.00%2,016,900Jun 30, 2024
J. SAFRA SARASIN HOLDING AG0.01%0.03%6,8716,871100.00%1,669,653Jun 30, 2024
ENTROPY TECHNOLOGIES, LP0.01%0.18%6,8496,849100.00%1,664,307Jun 30, 2024
NOMURA HOLDINGS INC0.01%0.00%6,4266,426100.00%1,561,518Jun 30, 2024
INCEPTIONR LLC0.00%0.37%5,3975,397100.00%1,311,471Jun 30, 2024
KNOLLWOOD INVESTMENT ADVISORY, LLC0.00%0.14%5,3555,355100.00%1,301,265Jun 30, 2024
DIVERSIFIED TRUST CO0.00%0.03%4,9784,978100.00%1,209,654Jun 30, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND0.00%0.00%4,7444,744100.00%1,152,792Jun 30, 2024
OMERS ADMINISTRATION CORP0.00%0.01%4,3614,361100.00%1,059,723Jun 30, 2024
STATE OF ALASKA, DEPARTMENT OF REVENUE0.00%0.01%4,2754,275100.00%1,038,000Jun 30, 2024
MACHINA CAPITAL S.A.S.0.00%0.47%4,2664,266100.00%1,036,638Jun 30, 2024
SPECTRUM PLANNING & ADVISORY SERVICES INC.0.00%0.85%3,5603,560100.00%879,320Jun 30, 2024
CHOREO, LLC0.00%0.01%3,1093,109100.00%756,356Jun 30, 2024
HIGHVISTA STRATEGIES LLC0.00%0.23%2,6022,602100.00%632,286Jun 30, 2024
CREDIT AGRICOLE S A0.00%0.00%2,5732,573100.00%625,239Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.00%0.00%2,3402,340100.00%568,620Jun 30, 2024
QUANTINNO CAPITAL MANAGEMENT LP0.00%0.01%2,2402,240100.00%544,320Jun 30, 2024
PALLAS CAPITAL ADVISORS LLC0.00%0.02%2,0522,052100.00%485,708Jun 30, 2024
ALGERT GLOBAL LLC0.00%0.02%1,9601,960100.00%476,000Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.00%0.03%1,8421,842100.00%448,000Jun 30, 2024
ATRIA INVESTMENTS, INC0.00%0.01%1,7581,758100.00%427,194Jun 30, 2024
UNITED CAPITAL FINANCIAL ADVISERS, LLC0.00%0.00%1,5201,520100.00%369,374Jun 30, 2024
COLONY GROUP, LLC0.00%0.00%1,4931,493100.00%363,000Jun 30, 2024
EVERHART FINANCIAL GROUP, INC.0.00%0.08%1,3221,322100.00%321,246Jun 30, 2024
EQIS CAPITAL MANAGEMENT, INC.0.00%0.03%1,2851,285100.00%312,303Jun 30, 2024
WEDMONT PRIVATE CAPITAL0.00%0.02%1,2341,234100.00%321,469Jun 30, 2024
DAI-ICHI LIFE INSURANCE COMPANY, LTD0.00%0.01%1,0771,077100.00%261,711Jun 30, 2024
BREAKWATER CAPITAL GROUP0.00%0.06%1,0251,025100.00%249,075Jun 30, 2024
FULTON BANK, N.A.0.00%0.01%1,0181,018100.00%247,374Jun 30, 2024
CENTIVA CAPITAL, LP0.00%0.00%1,0001,000100.00%243,000Jun 30, 2024
NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN0.00%0.03%1,0001,000100.00%243,000Jun 30, 2024
SUMMIT TRAIL ADVISORS, LLC0.00%0.01%929929100.00%225,747Jun 30, 2024
MERIT FINANCIAL GROUP, LLC0.00%0.01%928928100.00%225,504Jun 30, 2024
HCR WEALTH ADVISORS0.00%0.03%924924100.00%224,532Jun 30, 2024
FUKOKU MUTUAL LIFE INSURANCE CO0.00%0.02%914914100.00%222,102Jun 30, 2024
0.00%0.16%900900100.00%218,700Jun 30, 2024
SYM FINANCIAL CORP0.00%0.03%892892100.00%216,756Jun 30, 2024
NWAM LLC0.00%0.06%852852100.00%207,036Jun 30, 2024
COLDSTREAM CAPITAL MANAGEMENT INC0.00%0.01%843843100.00%204,849Jun 30, 2024
CHAPIN DAVIS, INC.0.00%0.07%825825100.00%200,475Jun 30, 2024
PALOMA PARTNERS MANAGEMENT CO0.00%0.01%800800100.00%194,400Jun 30, 2024
CSS LLC/IL0.00%0.01%700700100.00%170,100Jun 30, 2024
CSS LLC/IL0.00%0.01%500500100.00%121,500Jun 30, 2024
CONCORD WEALTH PARTNERS0.00%0.01%200200100.00%48,600Jun 30, 2024
ASHTON THOMAS PRIVATE WEALTH, LLC0.00%0.00%108108100.00%26,244Jun 30, 2024
PALOMA PARTNERS MANAGEMENT CO0.00%0.00%100100100.00%24,300Jun 30, 2024
HARTFORD FINANCIAL MANAGEMENT INC.0.00%0.01%100100100.00%24,300Jun 30, 2024
NVERSES CAPITAL, LLC0.00%0.01%100100100.00%24,300Jun 30, 2024
UNIQUE WEALTH STRATEGIES, LLC-0.00%2323100.00%3,437Jun 30, 2024
FINTRUST CAPITAL ADVISORS, LLC-0.00%1515100.00%3,645Jun 30, 2024
HARBOR INVESTMENT ADVISORY, LLC--11100.00%243Jun 30, 2024

Alnylam Pharmaceuticals's largest new institutional shareholder by number of shares is NORGES BANK, purchased 2.30M shares, valued at $558.12M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LOGOS GLOBAL MANAGEMENT LP----500,000-100.00%-Jun 30, 2024
VESTAL POINT CAPITAL, LP----350,000-100.00%-Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.----287,627-100.00%-Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC----234,400-100.00%-Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.----206,255-100.00%-Jun 30, 2024
PALO ALTO INVESTORS LP----182,766-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----110,759-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----90,234-100.00%-Jun 30, 2024
BARCLAYS PLC----60,200-100.00%-Jun 30, 2024
IKARIAN CAPITAL, LLC----51,541-100.00%-Jun 30, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC----50,000-100.00%-Jun 30, 2024
HRT FINANCIAL LP----41,927-100.00%-Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC----40,000-100.00%-Jun 30, 2024
PARNASSUS INVESTMENTS, LLC----38,748-100.00%-Jun 30, 2024
MEDIOLANUM INTERNATIONAL FUNDS LTD----38,556-100.00%-Jun 30, 2024
BANQUE PICTET & CIE SA----33,005-100.00%-Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP----32,500-100.00%-Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP----30,000-100.00%-Jun 30, 2024
SEVEN EIGHT CAPITAL, LP----25,809-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----25,000-100.00%-Jun 30, 2024
HAP TRADING, LLC----23,798-100.00%-Jun 30, 2024
SPHERA FUNDS MANAGEMENT LTD.----20,000-100.00%-Jun 30, 2024
SQUAREPOINT OPS LLC----20,000-100.00%-Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----18,658-100.00%-Jun 30, 2024
JUMP FINANCIAL, LLC----17,554-100.00%-Jun 30, 2024
POINT72 HONG KONG LTD----15,971-100.00%-Jun 30, 2024
TORNO CAPITAL, LLC----15,000-100.00%-Jun 30, 2024
ROCKEFELLER CAPITAL MANAGEMENT L.P.----10,715-100.00%-Jun 30, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC----10,614-100.00%-Jun 30, 2024
POINT72 (DIFC) LTD----10,363-100.00%-Jun 30, 2024
DLD ASSET MANAGEMENT, LP----10,000-100.00%-Jun 30, 2024
UBS GROUP AG----10,000-100.00%-Jun 30, 2024
ALPHA DNA INVESTMENT MANAGEMENT LLC----5,129-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----4,500-100.00%-Jun 30, 2024
STONERIDGE INVESTMENT PARTNERS LLC----4,200-100.00%-Jun 30, 2024
TEZA CAPITAL MANAGEMENT LLC----4,026-100.00%-Jun 30, 2024
HEADLANDS TECHNOLOGIES LLC----3,150-100.00%-Jun 30, 2024
CORTON CAPITAL INC.----3,004-100.00%-Jun 30, 2024
AQUILA INVESTMENT MANAGEMENT LLC----3,000-100.00%-Jun 30, 2024
FOX RUN MANAGEMENT, L.L.C.----2,988-100.00%-Jun 30, 2024
ALBERTA INVESTMENT MANAGEMENT CORP----2,900-100.00%-Jun 30, 2024
TWIN TREE MANAGEMENT, LP----2,900-100.00%-Jun 30, 2024
AIGEN INVESTMENT MANAGEMENT, LP----2,827-100.00%-Jun 30, 2024
SCIENTECH RESEARCH LLC----2,688-100.00%-Jun 30, 2024
PICTET & CIE (EUROPE) SA----2,562-100.00%-Jun 30, 2024
ASAHI LIFE ASSET MANAGEMENT CO., LTD.----2,150-100.00%-Jun 30, 2024
MOODY ALDRICH PARTNERS LLC----2,138-100.00%-Jun 30, 2024
FARALLON CAPITAL MANAGEMENT LLC----2,000-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----1,883-100.00%-Jun 30, 2024
ONTARIO TEACHERS PENSION PLAN BOARD----1,833-100.00%-Jun 30, 2024
ENTRYPOINT CAPITAL, LLC----1,724-100.00%-Jun 30, 2024
CANTOR FITZGERALD, L. P.----1,584-100.00%-Jun 30, 2024
WINTON GROUP LTD----1,471-100.00%-Jun 30, 2024
ABBREA CAPITAL, LLC----1,425-100.00%-Jun 30, 2024
PEARL RIVER CAPITAL, LLC----1,400-100.00%-Jun 30, 2024
WALLEYE CAPITAL LLC----1,400-100.00%-Jun 30, 2024
STEVENS CAPITAL MANAGEMENT LP----1,390-100.00%-Jun 30, 2024
OXFORD ASSET MANAGEMENT LLP----1,344-100.00%-Jun 30, 2024
RIVERVIEW TRUST CO----104-100.00%-Jun 30, 2024
ROYAL BANK OF CANADA----100-100.00%-Jun 30, 2024
YHB INVESTMENT ADVISORS, INC.----100-100.00%-Jun 30, 2024
MACROVIEW INVESTMENT MANAGEMENT LLC----51-100.00%-Jun 30, 2024
COLONIAL TRUST ADVISORS----9-100.00%-Jun 30, 2024
SOUTHSTATE CORP----6-100.00%-Jun 30, 2024
DT INVESTMENT PARTNERS, LLC----5-100.00%-Jun 30, 2024
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC----4-100.00%-Jun 30, 2024
CVA FAMILY OFFICE, LLC----3-100.00%-Jun 30, 2024
----3-100.00%-Jun 30, 2024
FINANCIAL GRAVITY ASSET MANAGEMENT, INC.----1-100.00%-Jun 30, 2024

Alnylam Pharmaceuticals's largest sold out institutional shareholder by shares sold is LOGOS GLOBAL MANAGEMENT LP, sold -0.50M shares, valued at -, as of undefined.

Alnylam Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
AMERICAN CENTURY GROWTH FUNDS, INC.1.21%188,760-24,198-11.36%Jan 31, 2024
PUTNAM CONVERTIBLE SECURITIES FUND1.07%5,228,000--Jan 31, 2024
Virtus Dividend, Interest & Premium Strategy Fund0.92%2,175,000--Jan 31, 2024
Virtus Equity & Convertible Income Fund0.91%1,810,000--Jan 31, 2024
CALAMOS STRATEGIC TOTAL RETURN FUND0.79%8,820,000--Jan 31, 2024
Virtus Diversified Income & Convertible Fund0.77%1,565,000--Jan 31, 2024
Virtus Artificial Intelligence & Technology Opportunities Fund0.76%3,000,000--Jan 31, 2024
Virtus Artificial Intelligence & Technology Opportunities Fund0.76%3,000,000--Jan 31, 2024
ADVENT CONVERTIBLE & INCOME FUND0.67%2,281,000--Jan 31, 2024
Virtus Strategy Trust0.56%11,860,000--Mar 28, 2024
Calamos Dynamic Convertible & Income Fund0.52%4,000,000--Jan 31, 2024
Virtus Convertible & Income Fund II0.52%1,960,000--Jan 31, 2024
Virtus Convertible & Income Fund0.50%2,485,000--Jan 31, 2024
Milliman Variable Insurance Trust0.50%208-2-0.95%Mar 31, 2024
FORUM FUNDS0.43%1,000,000--Jan 31, 2024
FIDELITY FINANCIAL TRUST0.43%7,620,000--Feb 29, 2024
HSBC FUNDS0.42%13,660--Jan 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.41%1,359,507183,88115.64%Mar 31, 2024
CALAMOS CONVERTIBLE & HIGH INCOME FUND0.40%5,000,000--Jan 31, 2024
AMCAP FUND0.39%3,331,9715,6480.17%Feb 29, 2024
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND0.39%4,500,000--Jan 31, 2024
Virtus Investment Trust0.36%12,410,000--Mar 28, 2024
Virtus Investment Trust0.36%12,410,000--Mar 28, 2024
GROWTH FUND OF AMERICA0.33%8,160,89138,8780.48%Feb 29, 2024
Virtus Equity & Convertible Income Fund0.31%615,000615,000-Jan 31, 2024
Capital Group Growth ETF0.31%119,64115,18614.54%Feb 29, 2024
Virtus Dividend, Interest & Premium Strategy Fund0.31%725,000725,000-Jan 31, 2024
CALAMOS INVESTMENT TRUST/IL0.30%31,545,000--Jan 31, 2024
NEW ECONOMY FUND0.28%1,269,690-193,240-13.21%Feb 29, 2024
T. Rowe Price New Horizons Fund, Inc.0.26%1,324,945-52,287-3.80%Mar 31, 2024
Virtus Diversified Income & Convertible Fund0.26%535,000535,000-Jan 31, 2024
Ultimus Managers Trust0.26%3,000,000--Feb 29, 2024
Tema ETF Trust0.21%9,3557,052306.21%Feb 29, 2024
Capital Group U.S. Equity Fund0.18%6,2791,24824.81%Jan 31, 2024
Virtus Convertible & Income Fund II0.18%665,000665,000-Jan 31, 2024
Virtus Convertible & Income Fund0.17%845,000845,000-Jan 31, 2024
AIM GROWTH SERIES (INVESCO GROWTH SERIES)0.17%5,270,000--Mar 31, 2024
MFS SERIES TRUST II0.17%527,419--Feb 29, 2024
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc.0.16%54,780-2,000-3.52%Mar 31, 2024
ELLSWORTH GROWTH & INCOME FUND LTD0.16%220,000--Dec 29, 2023
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC0.15%120,000--Dec 29, 2023
AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST)0.15%35,337,000--Feb 29, 2024
PIONEER SERIES TRUST XI0.15%73,034--Mar 28, 2024
UBS RELATIONSHIP FUNDS0.14%33,352--Jun 30, 2020
JP MORGAN MUTUAL FUND INVESTMENT TRUST0.14%523,468-519-0.10%Dec 31, 2023
TEKLA HEALTHCARE INVESTORS0.13%113,894-10,693-8.58%Mar 31, 2024
TEKLA LIFE SCIENCES INVESTORS0.13%60,121-3,062-4.85%Mar 31, 2024
BANCROFT FUND LTD0.12%160,000--Dec 29, 2023
VANGUARD VALLEY FORGE FUNDS0.11%55,0231700.31%Mar 31, 2024
VANGUARD SPECIALIZED FUNDS0.10%5,524,903--Jan 31, 2024
BlackRock Health Sciences Trust0.10%24,25511,24586.43%Mar 31, 2024
CALAMOS GLOBAL TOTAL RETURN FUND0.10%221,000--Jan 31, 2024
T. Rowe Price Mid-Cap Growth Fund, Inc.0.09%1,398,000-272,800-16.33%Mar 31, 2024
Voya VARIABLE PRODUCTS TRUST0.09%32,654--Mar 31, 2024
PIONEER SERIES TRUST XII0.09%65,448-4,161-5.98%Feb 29, 2024
Calamos Global Dynamic Income Fund0.08%969,000--Jan 31, 2024
BNY MELLON RESEARCH GROWTH FUND, INC.0.08%46,44746,447-Feb 29, 2024
NEW PERSPECTIVE FUND0.08%2,409,705-908,976-27.39%Mar 31, 2024
BlackRock Health Sciences Trust II0.08%208,667105,700102.65%Mar 31, 2024
FIDELITY MT VERNON STREET TRUST0.08%2,229,905-407,033-15.44%Feb 29, 2024
FIDELITY ADVISOR SERIES VII0.07%576,486235,00068.82%Jan 31, 2024
AMERICAN FUNDS FUNDAMENTAL INVESTORS0.07%1,364,643-1,261,621-48.04%Mar 31, 2024
LORD ABBETT SECURITIES TRUST0.06%297,712--Jan 31, 2024
Humankind Benefit Corp0.06%1,27012811.21%Dec 31, 2023
T. Rowe Price Equity Series, Inc.0.05%89,9864,1374.82%Mar 31, 2024
LAUDUS TRUST0.05%26,47018,582235.57%Mar 31, 2024
MFS SERIES TRUST IV0.05%167,327--Feb 29, 2024
MAINSTAY VP FUNDS TRUST0.05%5,744,000--Mar 31, 2024
Voya PARTNERS INC0.04%3,300,000--Mar 31, 2024
Voya PARTNERS INC0.04%3,300,000--Mar 31, 2024
PUTNAM GLOBAL HEALTH CARE FUND0.04%65,500--Feb 29, 2024
Cushing Mutual Funds Trust0.04%1,133--Aug 31, 2023
Natixis ETF Trust II0.03%563--Mar 31, 2024
HARBOR FUNDS0.03%692,000--Jan 31, 2024
Engine No. 1 ETF Trust0.03%1,753-91-4.93%Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND IV0.03%70,50018,50035.58%Mar 31, 2024
PARNASSUS FUNDS0.03%38,748--Mar 31, 2024
DELAWARE GROUP EQUITY FUNDS IV0.03%30,000-11,079-26.97%Mar 28, 2024
VANGUARD INDEX FUNDS0.03%10,697,198-1,847,728-14.73%Mar 31, 2024
T. Rowe Price Tax-Efficient Funds, Inc.0.02%2,301--Feb 29, 2024
MAINSTAY FUNDS0.02%5,460,000--Jan 31, 2024
FIDELITY SECURITIES FUND0.02%2,068,831-29,027-1.38%Jan 31, 2024
REYNOLDS FUNDS INC0.02%250--Mar 31, 2024
LORD ABBETT RESEARCH FUND INC0.02%21,264--Feb 29, 2024
T. Rowe Price Equity Funds, Inc.0.02%240,822-63,478-20.86%Mar 31, 2024
FIDELITY DESTINY PORTFOLIOS0.02%47,6004,60010.70%Mar 31, 2024
TOCQUEVILLE TRUST0.02%3,000--Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.02%203,519-36,292-15.13%Mar 31, 2024
FIDELITY CAPITAL TRUST0.02%208,50011,4005.78%Jan 31, 2024
AMERICAN CENTURY MUTUAL FUNDS, INC.0.02%183,000-89,876-32.94%Jan 31, 2024
Advantage Advisers Xanthus Fund, L.L.C.0.02%53,694--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.02%1,093,553292,60036.53%Feb 29, 2024
Calvert Responsible Index Series, Inc.0.02%26,406--Mar 31, 2024
Capital Group Global Growth Equity ETF0.02%18,264--Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND0.02%326,4243,3001.02%Mar 31, 2024
FRANKLIN STRATEGIC SERIES0.01%126,200--Jan 31, 2024
Voya EQUITY TRUST0.01%21,170--Feb 29, 2024
JNL VARIABLE FUND LLC0.01%80,997-3,198-3.80%Mar 31, 2020
TIAA SEPARATE ACCOUNT VA 10.01%3,180--Mar 31, 2024
LORD ABBETT INVESTMENT TRUST0.01%13,677,000--Feb 29, 2024

Alnylam Pharmaceuticals's largest mutual fund holder by % of total assets is "AMERICAN CENTURY GROWTH FUNDS, INC.", owning 188.76K shares, compromising 1.21% of its total assets.

Alnylam Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 245601.27%
31 Mar, 245533.56%
31 Dec, 235348.32%
30 Sep, 234930.61%
30 Jun, 23490-1.01%
31 Mar, 23495-3.32%
31 Dec, 22512-0.39%
30 Sep, 2251413.72%
30 Jun, 22452-2.38%
31 Mar, 224631.31%
31 Dec, 214578.04%
30 Sep, 21423-3.64%
30 Jun, 214397.33%
31 Mar, 214092.25%
31 Dec, 204004.17%
30 Sep, 20384-3.27%
30 Jun, 2039710.58%
31 Mar, 203594.36%
31 Dec, 1934411.33%
30 Sep, 19309-1.28%
30 Jun, 19313-0.32%
31 Mar, 193142.28%
31 Dec, 18307-10.50%
30 Sep, 183432.08%
30 Jun, 183364.35%
31 Mar, 183224.21%
31 Dec, 1730911.96%
30 Sep, 1727610.84%
30 Jun, 1724910.67%
31 Mar, 17225-2.17%
31 Dec, 16230-18.73%
30 Sep, 162834.81%
30 Jun, 16270-2.17%
31 Mar, 162761.10%
31 Dec, 15273-0.36%
30 Sep, 15274-7.12%
30 Jun, 1529515.69%
31 Mar, 1525511.35%
31 Dec, 1422915.66%
30 Sep, 14198-6.16%
30 Jun, 14211-2.76%
31 Mar, 1421719.89%
31 Dec, 13181-0.55%
30 Sep, 1318221.33%
30 Jun, 13150154.24%
31 Mar, 135934.09%
31 Dec, 1244-20.00%
30 Sep, 125525.00%
30 Jun, 1244-6.38%
31 Mar, 124720.51%
31 Dec, 113925.81%
30 Sep, 1131-
30 Jun, 1131-3.13%
31 Mar, 11323.23%
31 Dec, 103134.78%
30 Sep, 1023-8.00%
30 Jun, 102519.05%
31 Mar, 1021-4.55%
31 Dec, 0922-18.52%
30 Sep, 0927-22.86%
30 Jun, 09359.38%
31 Mar, 0932-13.51%
31 Dec, 083727.59%
30 Sep, 08297.41%
30 Jun, 0827-10.00%
31 Mar, 0830-3.23%
31 Dec, 073140.91%
30 Sep, 0722-15.38%
30 Jun, 07264.00%
31 Mar, 07254.17%
31 Dec, 06249.09%
30 Sep, 062237.50%
30 Jun, 061614.29%
31 Mar, 0614100.00%
31 Dec, 057-12.50%
30 Sep, 058166.67%
30 Jun, 053-25.00%
31 Mar, 05433.33%
31 Dec, 043200.00%
30 Sep, 041-
30 Jun, 041-

As of 30 Jun 24, 560 institutions are holding Alnylam Pharmaceuticals's shares, representing an increase of 1.27% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 24119,859,6996.53%
31 Mar, 24112,509,382-3.80%
31 Dec, 23116,949,4790.55%
30 Sep, 23116,310,429-1.58%
30 Jun, 23118,175,400-0.98%
31 Mar, 23119,339,488-0.11%
31 Dec, 22119,469,955-10.10%
30 Sep, 22132,884,74517.62%
30 Jun, 22112,981,167-0.42%
31 Mar, 22113,456,2281.74%
31 Dec, 21111,519,6960.37%
30 Sep, 21111,104,698-0.64%
30 Jun, 21111,817,0682.64%
31 Mar, 21108,937,6880.97%
31 Dec, 20107,886,144-0.40%
30 Sep, 20108,319,172-2.80%
30 Jun, 20111,436,1242.92%
31 Mar, 20108,277,5532.42%
31 Dec, 19105,718,192-2.06%
30 Sep, 19107,943,3731.85%
30 Jun, 19105,982,6229.50%
31 Mar, 1996,786,5674.73%
31 Dec, 1892,415,1901.95%
30 Sep, 1890,651,136-0.94%
30 Jun, 1891,515,814-0.14%
31 Mar, 1891,640,033-0.57%
31 Dec, 1792,168,5935.31%
30 Sep, 1787,520,4660.35%
30 Jun, 1787,213,3975.97%
31 Mar, 1782,298,8942.97%
31 Dec, 1679,928,1173.07%
30 Sep, 1677,546,9834.63%
30 Jun, 1674,115,1612.82%
31 Mar, 1672,084,5999.15%
31 Dec, 1566,043,326-14.28%
30 Sep, 1577,043,36417.50%
30 Jun, 1565,567,2821.69%
31 Mar, 1564,475,42011.14%
31 Dec, 1458,012,605-1.64%
30 Sep, 1458,982,6492.07%
30 Jun, 1457,784,9003.73%
31 Mar, 1455,705,2260.73%
31 Dec, 1355,301,1947.94%
30 Sep, 1351,233,40710.19%
30 Jun, 1346,496,93397.84%
31 Mar, 1323,502,73239.39%
31 Dec, 1216,861,0315.78%
30 Sep, 1215,939,542-12.16%
30 Jun, 1218,146,235-9.37%
31 Mar, 1220,022,78362.30%
31 Dec, 1112,336,6947.12%
30 Sep, 1111,516,326-14.30%
30 Jun, 1113,437,26283.04%
31 Mar, 117,341,13134.06%
31 Dec, 105,475,99385.01%
30 Sep, 102,959,763-9.18%
30 Jun, 103,258,845-23.89%
31 Mar, 104,281,80121.55%
31 Dec, 093,522,595-4.62%
30 Sep, 093,693,34715.21%
30 Jun, 093,205,857-65.73%
31 Mar, 099,354,874-27.95%
31 Dec, 0812,983,088262.33%
30 Sep, 083,583,2626.43%
30 Jun, 083,366,795-1.57%
31 Mar, 083,420,618-59.04%
31 Dec, 078,351,6920.84%
30 Sep, 078,282,366-15.77%
30 Jun, 079,833,574125.52%
31 Mar, 074,360,486-53.54%
31 Dec, 069,386,14310.86%
30 Sep, 068,466,37437.12%
30 Jun, 066,174,506112.92%
31 Mar, 062,899,862307.93%
31 Dec, 05710,870-79.66%
30 Sep, 053,494,690853.34%
30 Jun, 05366,57268.14%
31 Mar, 05218,017-83.89%
31 Dec, 041,353,71019.78%
30 Sep, 041,130,200-13.01%
30 Jun, 041,299,293-

Alnylam Pharmaceuticals (ALNY) has 119.86M shares outstanding as of 30 Jun 24, up 6.53% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2495.02%1.19%
31 Mar, 2489.20%1.02%
31 Dec, 2393.63%1.09%
30 Sep, 2392.88%1.03%
30 Jun, 2394.80%1.03%
31 Mar, 2396.16%1.00%
31 Dec, 2298.18%0.83%
30 Sep, 22108.77%1.25%
30 Jun, 2293.45%1.05%
31 Mar, 2294.41%1.09%
31 Dec, 2193.11%1.07%
30 Sep, 2193.44%1.04%
30 Jun, 2194.94%1.10%
31 Mar, 2193.05%1.06%
31 Dec, 2093.83%1.08%
30 Sep, 2093.39%0.99%
30 Jun, 2096.98%1.05%
31 Mar, 2096.03%1.03%
31 Dec, 1996.75%0.98%
30 Sep, 1999.30%1.04%
30 Jun, 1997.61%1.16%
31 Mar, 1991.83%1.10%
31 Dec, 1891.44%1.13%
30 Sep, 1889.95%1.09%
30 Jun, 1891.04%1.08%
31 Mar, 1891.66%1.00%
31 Dec, 1795.87%1.06%
30 Sep, 1795.31%0.97%
30 Jun, 1799.00%1.08%
31 Mar, 1795.67%1.10%
31 Dec, 1693.38%1.14%
30 Sep, 1690.47%1.21%
30 Jun, 1686.64%1.21%
31 Mar, 1684.53%1.37%
31 Dec, 1578.63%0.95%
30 Sep, 1591.03%1.51%
30 Jun, 1577.73%1.26%
31 Mar, 1578.56%1.29%
31 Dec, 1478.10%1.31%
30 Sep, 1477.19%1.33%
30 Jun, 1476.20%1.13%
31 Mar, 1482.18%1.06%
31 Dec, 1387.91%1.30%
30 Sep, 1382.08%1.44%
30 Jun, 1375.41%4.78%
31 Mar, 1339.72%3.75%
31 Dec, 1232.54%3.40%
30 Sep, 1230.93%2.47%
30 Jun, 1235.39%1.88%
31 Mar, 1243.33%5.12%
31 Dec, 1129.09%3.99%
30 Sep, 1127.00%2.69%
30 Jun, 1131.71%10.55%
31 Mar, 1117.34%10.22%
31 Dec, 1013.03%26.38%
30 Sep, 107.03%11.67%
30 Jun, 107.76%7.42%
31 Mar, 1010.23%14.45%
31 Dec, 098.41%10.73%
30 Sep, 098.86%14.85%
30 Jun, 097.72%1.51%
31 Mar, 0922.60%2.26%
31 Dec, 0831.61%41.78%
30 Sep, 088.70%12.84%
30 Jun, 088.23%11.67%
31 Mar, 088.40%1.99%
31 Dec, 0720.53%4.56%
30 Sep, 0721.22%3.09%
30 Jun, 0726.20%19.25%
31 Mar, 0711.67%1.85%
31 Dec, 0625.11%3.61%
30 Sep, 0626.36%7.08%
30 Jun, 0619.29%20.68%
31 Mar, 069.66%92.07%
31 Dec, 053.24%1.16%
30 Sep, 0516.71%528.00%
30 Jun, 051.78%156.29%
31 Mar, 051.07%2.43%
31 Dec, 046.62%21.66%
30 Sep, 045.53%1.60%
30 Jun, 0418.57%-

As of 30 Jun 24, Alnylam Pharmaceuticals is held by 95.02% institutional shareholders, representing a 1.19% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 242812.55%
31 Mar, 242743.40%
31 Dec, 2326528.02%
30 Sep, 23207-2.82%
30 Jun, 23213-6.17%
31 Mar, 23227-9.92%
31 Dec, 22252-11.27%
30 Sep, 2228451.87%
30 Jun, 22187-16.89%
31 Mar, 22225-3.85%
31 Dec, 2123414.71%
30 Sep, 212044.08%
30 Jun, 21196-2.97%
31 Mar, 2120216.76%
31 Dec, 2017310.19%
30 Sep, 20157-25.24%
30 Jun, 2021021.39%
31 Mar, 20173-
31 Dec, 1917320.98%
30 Sep, 19143-7.14%
30 Jun, 191540.65%
31 Mar, 1915310.87%
31 Dec, 18138-10.39%
30 Sep, 18154-13.48%
30 Jun, 181787.23%
31 Mar, 18166-4.60%
31 Dec, 1717445.00%
30 Sep, 17120-8.40%
30 Jun, 1713132.32%
31 Mar, 1799-10.81%
31 Dec, 16111-3.48%
30 Sep, 16115-20.69%
30 Jun, 16145-2.03%
31 Mar, 161485.71%
31 Dec, 151406.87%
30 Sep, 15131-24.28%
30 Jun, 1517314.57%
31 Mar, 1515139.81%
31 Dec, 1410830.12%
30 Sep, 1483-18.63%
30 Jun, 14102-12.82%
31 Mar, 1411732.95%
31 Dec, 1388-16.98%
30 Sep, 13106-4.50%
30 Jun, 13111164.29%
31 Mar, 134275.00%
31 Dec, 1224-29.41%
30 Sep, 123436.00%
30 Jun, 1225-26.47%
31 Mar, 123430.77%
31 Dec, 112662.50%
30 Sep, 1116-
30 Jun, 1116-
31 Mar, 1116-23.81%
31 Dec, 1021133.33%
30 Sep, 109-25.00%
30 Jun, 101220.00%
31 Mar, 1010-
31 Dec, 0910-16.67%
30 Sep, 0912-42.86%
30 Jun, 0921-16.00%
31 Mar, 0925-16.67%
31 Dec, 083087.50%
30 Sep, 0816-11.11%
30 Jun, 0818-5.26%
31 Mar, 08195.56%
31 Dec, 0718157.14%
30 Sep, 077-50.00%
30 Jun, 0714-26.32%
31 Mar, 071918.75%
31 Dec, 0616-
30 Sep, 061633.33%
30 Jun, 061220.00%
31 Mar, 0610100.00%
31 Dec, 055-28.57%
30 Sep, 057133.33%
30 Jun, 053200.00%
31 Mar, 051-66.67%
31 Dec, 043-
30 Sep, 04--100.00%
30 Jun, 041-

281 institutional shareholders have increased their position in ALNY stock as of 30 Jun 24 compared to 274 in the previous quarter (a 2.55% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 241601.91%
31 Mar, 241571.95%
31 Dec, 23154-7.23%
30 Sep, 231667.79%
30 Jun, 23154-8.33%
31 Mar, 2316810.53%
31 Dec, 221521.33%
30 Sep, 22150-8.54%
30 Jun, 2216415.49%
31 Mar, 2214211.81%
31 Dec, 211276.72%
30 Sep, 21119-9.85%
30 Jun, 2113212.82%
31 Mar, 21117-6.40%
31 Dec, 20125-0.79%
30 Sep, 2012613.51%
30 Jun, 2011111.00%
31 Mar, 201005.26%
31 Dec, 199523.38%
30 Sep, 1977-
30 Jun, 1977-11.49%
31 Mar, 1987-12.12%
31 Dec, 18996.45%
30 Sep, 189313.41%
30 Jun, 1882-6.82%
31 Mar, 188822.22%
31 Dec, 1772-14.29%
30 Sep, 178429.23%
30 Jun, 1765-8.45%
31 Mar, 1771-1.39%
31 Dec, 1672-18.18%
30 Sep, 168841.94%
30 Jun, 1662-1.59%
31 Mar, 1663-17.11%
31 Dec, 1576-12.64%
30 Sep, 15876.10%
30 Jun, 158232.26%
31 Mar, 1562-27.91%
31 Dec, 148628.36%
30 Sep, 1467-8.22%
30 Jun, 147315.87%
31 Mar, 1463-7.35%
31 Dec, 136828.30%
30 Sep, 1353112.00%
30 Jun, 1325212.50%
31 Mar, 138-27.27%
31 Dec, 1211-8.33%
30 Sep, 121220.00%
30 Jun, 121066.67%
31 Mar, 126-14.29%
31 Dec, 117-
30 Sep, 117-22.22%
30 Jun, 11912.50%
31 Mar, 118300.00%
31 Dec, 102-66.67%
30 Sep, 106-14.29%
30 Jun, 10716.67%
31 Mar, 10620.00%
31 Dec, 095-16.67%
30 Sep, 096-33.33%
30 Jun, 09980.00%
31 Mar, 095-
31 Dec, 085-50.00%
30 Sep, 0810100.00%
30 Jun, 085-28.57%
31 Mar, 087-
31 Dec, 077-30.00%
30 Sep, 071066.67%
30 Jun, 07650.00%
31 Mar, 074-
31 Dec, 064300.00%
30 Sep, 061-
30 Jun, 06--100.00%
31 Mar, 062100.00%
31 Dec, 051-
30 Sep, 051-
30 Jun, 05--100.00%
31 Mar, 052-
31 Dec, 04--100.00%
30 Sep, 041-
30 Jun, 04--

160 institutional shareholders have reduced their position in ALNY stock as of 30 Jun 24 compared to 157 in the previous quarter (a 1.91% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 245601.27%119,859,6996.53%95.02%1.19%2812.55%1601.91%
31 Mar, 245533.56%112,509,382-3.80%89.20%1.02%2743.40%1571.95%
31 Dec, 235348.32%116,949,4790.55%93.63%1.09%26528.02%154-7.23%
30 Sep, 234930.61%116,310,429-1.58%92.88%1.03%207-2.82%1667.79%
30 Jun, 23490-1.01%118,175,400-0.98%94.80%1.03%213-6.17%154-8.33%
31 Mar, 23495-3.32%119,339,488-0.11%96.16%1.00%227-9.92%16810.53%
31 Dec, 22512-0.39%119,469,955-10.10%98.18%0.83%252-11.27%1521.33%
30 Sep, 2251413.72%132,884,74517.62%108.77%1.25%28451.87%150-8.54%
30 Jun, 22452-2.38%112,981,167-0.42%93.45%1.05%187-16.89%16415.49%
31 Mar, 224631.31%113,456,2281.74%94.41%1.09%225-3.85%14211.81%
31 Dec, 214578.04%111,519,6960.37%93.11%1.07%23414.71%1276.72%
30 Sep, 21423-3.64%111,104,698-0.64%93.44%1.04%2044.08%119-9.85%
30 Jun, 214397.33%111,817,0682.64%94.94%1.10%196-2.97%13212.82%
31 Mar, 214092.25%108,937,6880.97%93.05%1.06%20216.76%117-6.40%
31 Dec, 204004.17%107,886,144-0.40%93.83%1.08%17310.19%125-0.79%
30 Sep, 20384-3.27%108,319,172-2.80%93.39%0.99%157-25.24%12613.51%
30 Jun, 2039710.58%111,436,1242.92%96.98%1.05%21021.39%11111.00%
31 Mar, 203594.36%108,277,5532.42%96.03%1.03%173-1005.26%
31 Dec, 1934411.33%105,718,192-2.06%96.75%0.98%17320.98%9523.38%
30 Sep, 19309-1.28%107,943,3731.85%99.30%1.04%143-7.14%77-
30 Jun, 19313-0.32%105,982,6229.50%97.61%1.16%1540.65%77-11.49%
31 Mar, 193142.28%96,786,5674.73%91.83%1.10%15310.87%87-12.12%
31 Dec, 18307-10.50%92,415,1901.95%91.44%1.13%138-10.39%996.45%
30 Sep, 183432.08%90,651,136-0.94%89.95%1.09%154-13.48%9313.41%
30 Jun, 183364.35%91,515,814-0.14%91.04%1.08%1787.23%82-6.82%
31 Mar, 183224.21%91,640,033-0.57%91.66%1.00%166-4.60%8822.22%
31 Dec, 1730911.96%92,168,5935.31%95.87%1.06%17445.00%72-14.29%
30 Sep, 1727610.84%87,520,4660.35%95.31%0.97%120-8.40%8429.23%
30 Jun, 1724910.67%87,213,3975.97%99.00%1.08%13132.32%65-8.45%
31 Mar, 17225-2.17%82,298,8942.97%95.67%1.10%99-10.81%71-1.39%
31 Dec, 16230-18.73%79,928,1173.07%93.38%1.14%111-3.48%72-18.18%
30 Sep, 162834.81%77,546,9834.63%90.47%1.21%115-20.69%8841.94%
30 Jun, 16270-2.17%74,115,1612.82%86.64%1.21%145-2.03%62-1.59%
31 Mar, 162761.10%72,084,5999.15%84.53%1.37%1485.71%63-17.11%
31 Dec, 15273-0.36%66,043,326-14.28%78.63%0.95%1406.87%76-12.64%
30 Sep, 15274-7.12%77,043,36417.50%91.03%1.51%131-24.28%876.10%
30 Jun, 1529515.69%65,567,2821.69%77.73%1.26%17314.57%8232.26%
31 Mar, 1525511.35%64,475,42011.14%78.56%1.29%15139.81%62-27.91%
31 Dec, 1422915.66%58,012,605-1.64%78.10%1.31%10830.12%8628.36%
30 Sep, 14198-6.16%58,982,6492.07%77.19%1.33%83-18.63%67-8.22%
30 Jun, 14211-2.76%57,784,9003.73%76.20%1.13%102-12.82%7315.87%
31 Mar, 1421719.89%55,705,2260.73%82.18%1.06%11732.95%63-7.35%
31 Dec, 13181-0.55%55,301,1947.94%87.91%1.30%88-16.98%6828.30%
30 Sep, 1318221.33%51,233,40710.19%82.08%1.44%106-4.50%53112.00%
30 Jun, 13150154.24%46,496,93397.84%75.41%4.78%111164.29%25212.50%
31 Mar, 135934.09%23,502,73239.39%39.72%3.75%4275.00%8-27.27%
31 Dec, 1244-20.00%16,861,0315.78%32.54%3.40%24-29.41%11-8.33%
30 Sep, 125525.00%15,939,542-12.16%30.93%2.47%3436.00%1220.00%
30 Jun, 1244-6.38%18,146,235-9.37%35.39%1.88%25-26.47%1066.67%
31 Mar, 124720.51%20,022,78362.30%43.33%5.12%3430.77%6-14.29%
31 Dec, 113925.81%12,336,6947.12%29.09%3.99%2662.50%7-
30 Sep, 1131-11,516,326-14.30%27.00%2.69%16-7-22.22%
30 Jun, 1131-3.13%13,437,26283.04%31.71%10.55%16-912.50%
31 Mar, 11323.23%7,341,13134.06%17.34%10.22%16-23.81%8300.00%
31 Dec, 103134.78%5,475,99385.01%13.03%26.38%21133.33%2-66.67%
30 Sep, 1023-8.00%2,959,763-9.18%7.03%11.67%9-25.00%6-14.29%
30 Jun, 102519.05%3,258,845-23.89%7.76%7.42%1220.00%716.67%
31 Mar, 1021-4.55%4,281,80121.55%10.23%14.45%10-620.00%
31 Dec, 0922-18.52%3,522,595-4.62%8.41%10.73%10-16.67%5-16.67%
30 Sep, 0927-22.86%3,693,34715.21%8.86%14.85%12-42.86%6-33.33%
30 Jun, 09359.38%3,205,857-65.73%7.72%1.51%21-16.00%980.00%
31 Mar, 0932-13.51%9,354,874-27.95%22.60%2.26%25-16.67%5-
31 Dec, 083727.59%12,983,088262.33%31.61%41.78%3087.50%5-50.00%
30 Sep, 08297.41%3,583,2626.43%8.70%12.84%16-11.11%10100.00%
30 Jun, 0827-10.00%3,366,795-1.57%8.23%11.67%18-5.26%5-28.57%
31 Mar, 0830-3.23%3,420,618-59.04%8.40%1.99%195.56%7-
31 Dec, 073140.91%8,351,6920.84%20.53%4.56%18157.14%7-30.00%
30 Sep, 0722-15.38%8,282,366-15.77%21.22%3.09%7-50.00%1066.67%
30 Jun, 07264.00%9,833,574125.52%26.20%19.25%14-26.32%650.00%
31 Mar, 07254.17%4,360,486-53.54%11.67%1.85%1918.75%4-
31 Dec, 06249.09%9,386,14310.86%25.11%3.61%16-4300.00%
30 Sep, 062237.50%8,466,37437.12%26.36%7.08%1633.33%1-
30 Jun, 061614.29%6,174,506112.92%19.29%20.68%1220.00%--100.00%
31 Mar, 0614100.00%2,899,862307.93%9.66%92.07%10100.00%2100.00%
31 Dec, 057-12.50%710,870-79.66%3.24%1.16%5-28.57%1-
30 Sep, 058166.67%3,494,690853.34%16.71%528.00%7133.33%1-
30 Jun, 053-25.00%366,57268.14%1.78%156.29%3200.00%--100.00%
31 Mar, 05433.33%218,017-83.89%1.07%2.43%1-66.67%2-
31 Dec, 043200.00%1,353,71019.78%6.62%21.66%3---100.00%
30 Sep, 041-1,130,200-13.01%5.53%1.60%--100.00%1-
30 Jun, 041-1,299,293-18.57%-1---

Alnylam Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell1,421$268.66$381.77K33,485
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell9,662$270.17$2.61M23,823
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell5,736$271.32$1.56M18,087
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell3,913$272.43$1.07M14,174
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell1,158$273.73$316.98K13,016
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell135$274.65$37.08K12,881
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell1,627$259.56$422.30K18,759
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell3,742$260.40$974.42K15,017
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell6,212$261.63$1.63M8,805
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell4,367$262.79$1.15M4,438
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell3,408$263.72$898.76K1,030
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell632$264.95$167.45K398
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell262$266.45$69.81K136

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell1,421$268.66$381.77K33,485
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell9,662$270.17$2.61M23,823
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell5,736$271.32$1.56M18,087
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell3,913$272.43$1.07M14,174
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell1,158$273.73$316.98K13,016
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell135$274.65$37.08K12,881
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchM-ExemptSell14,058$85.00$1.19M2,192
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchM-ExemptSell6,667$97.72$651.50K-
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell1,627$259.56$422.30K18,759
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell3,742$260.40$974.42K15,017
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell6,212$261.63$1.63M8,805
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell4,367$262.79$1.15M4,438
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell3,408$263.72$898.76K1,030
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell632$264.95$167.45K398
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell262$266.45$69.81K136
Aug 08, 2024Ausiello Dennis Adirector-M-ExemptSell9,000$105.26$947.34K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchM-ExemptBuy14,058$85.00$1.19M34,906
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell1,421$268.66$381.77K33,485
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell9,662$270.17$2.61M23,823
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchM-ExemptBuy6,667$97.72$651.50K20,848
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell5,736$271.32$1.56M18,087
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell3,913$272.43$1.07M14,174
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell1,158$273.73$316.98K13,016
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchS-SaleSell135$274.65$37.08K12,881
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchM-ExemptSell14,058$85.00$1.19M2,192
Aug 14, 2024Fitzgerald Kevin Josephofficer CSO & EVP, Head of ResearchM-ExemptSell6,667$97.72$651.50K-
Aug 08, 2024Ausiello Dennis Adirector-M-ExemptBuy9,000$105.26$947.34K20,386
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell1,627$259.56$422.30K18,759
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell3,742$260.40$974.42K15,017
Aug 08, 2024Ausiello Dennis Adirector-M-ExemptBuy11,250$131.21$1.48M11,386
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell6,212$261.63$1.63M8,805
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell4,367$262.79$1.15M4,438
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell3,408$263.72$898.76K1,030
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell632$264.95$167.45K398
Aug 08, 2024Ausiello Dennis Adirector-S-SaleSell262$266.45$69.81K136
Aug 08, 2024Ausiello Dennis Adirector-M-ExemptSell9,000$105.26$947.34K-

The last insider sell of Alnylam Pharmaceuticals's stock was made by Fitzgerald Kevin Joseph on Aug 14 2024, selling 1,421 shares at $268.66 per share (valued at $381.77K).

Alnylam Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 202452025.00%
Q2 2024217229.17%
Q1 2024196230.65%
Q4 20231250.00%
Q3 202393525.71%
Q2 2023153246.88%
Q1 2023252986.21%
Q4 202251145.45%
Q3 2022173745.95%
Q2 20221712141.67%
Q1 2022144350.00%
Q4 2021114524.44%
Q3 20211918105.56%
Q2 202183026.67%
Q1 2021193652.78%
Q4 202041330.77%
Q3 2020263476.47%
Q2 2020143243.75%
Q1 2020213265.63%
Q4 20192320115.00%

5 total buy trades, and 20 total sell trades (buy/sell ratio of 0.25%) were made by Alnylam Pharmaceuticals's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-15-
Q2 2024-67-
Q1 2024-46-
Q4 2023-1-
Q3 2023-34-
Q2 2023-32-
Q1 2023-19-
Q4 2022-1-
Q3 2022-16-
Q2 2022-10-
Q1 2022-1-
Q4 2021-22-
Q3 2021-10-
Q2 2021-17-
Q1 2021-18-
Q4 2020-9-
Q3 2020-16-
Q2 2020-13-
Q1 2020-19-
Q4 2019-9-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 15 open market sell trades of Alnylam Pharmaceuticals's stocks.

Alnylam Pharmaceuticals Peer Ownership


TickerCompany
INCYIncyte Corporation
APLSApellis Pharmaceuticals, Inc.
BPMCBlueprint Medicines Corporation
HALOHalozyme Therapeutics, Inc.
EXELExelixis, Inc.
DAWNDay One Biopharmaceuticals, Inc.
BMRNBioMarin Pharmaceutical Inc.
PRQRProQR Therapeutics N.V.
WVEWave Life Sciences Ltd.
KRYSKrystal Biotech, Inc.
UTHRUnited Therapeutics Corporation
KRTXKaruna Therapeutics, Inc.
RAREUltragenyx Pharmaceutical Inc.
MDGLMadrigal Pharmaceuticals, Inc.
AMLXAmylyx Pharmaceuticals, Inc.

ALNY Ownership FAQ


Alnylam Pharmaceuticals is owned by institutional shareholders (95.02%), insiders (0.42%), and public (4.56%). The largest institutional shareholder of Alnylam Pharmaceuticals is CAPITAL WORLD INVESTORS (11.87% of total shares) and the top mutual fund owner is AMERICAN CENTURY GROWTH FUNDS, INC. (1.21% of total shares).

Alnylam Pharmaceuticals's major institutional shareholders are CAPITAL WORLD INVESTORS, VANGUARD GROUP INC, FMR LLC, BLACKROCK INC., and WELLINGTON MANAGEMENT GROUP LLP. The top five shareholders own together 43.92% of the company's share outstanding.

As of Jun 2024, there are 560 institutional shareholders of Alnylam Pharmaceuticals.

CAPITAL WORLD INVESTORS owns 14.97M shares of Alnylam Pharmaceuticals, representing 11.87% of the company's total shares outstanding, valued at $3.64B (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 12.51M shares of Alnylam Pharmaceuticals (ALNY), compromising 9.92% of the company, valued at $3.04B.

FMR LLC is the third largest holder of Alnylam Pharmaceuticals. The company owns 12.16M of the company's shares outstanding (worth $2.96B).